Richard F. Little

Ibrutinib Regimens versus Chemoimmunotherapy in Older Patients with Untreated CLL

Jennifer A. Woyach, Amy S. Ruppert, Nyla A. Heerema et al. · New England Journal of Medicine · 2018 · 927 citations · Full text

Ibrutinib–Rituximab or Chemoimmunotherapy for Chronic Lymphocytic Leukemia

Tait D. Shanafelt, Xin V. Wang, Neil E. Kay et al. · New England Journal of Medicine · 2019 · 715 citations · Full text

Inhibition of B Cell Receptor Signaling by Ibrutinib in Primary CNS Lymphoma

Michail S. Lionakis, Kieron Dunleavy, Mark Roschewski et al. · Cancer Cell · 2017 · 484 citations · Full text

Lymphoid Neoplasia, Malignant Blood Disorder, Primary Cns Lymphoma +5

Low-Intensity Therapy in Adults with Burkitt's Lymphoma

Kieron Dunleavy, Stefania Pittaluga, Margaret Shovlin et al. · New England Journal of Medicine · 2013 · 357 citations · Full text

Highly effective treatment of acquired immunodeficiency syndrome–related lymphoma with dose-adjusted EPOCH: impact of antiretroviral therapy suspension and tumor biology

Richard F. Little, Stefania Pittaluga, Nicole Grant et al. · Blood · 2003 · 355 citations